Proposed Tariffs on Pharmaceuticals Could Boost Local Supply Chain Resilience
The U.S. government is setting the stage for a major shift in pharmaceutical manufacturing strategy, with President Donald Trump announcing plans to introduce tariffs on imported medicines. The move—designed to encourage companies to bring production back to the U.S.—could pave the way for a more resilient and regionally integrated supply chain in the healthcare sector.…